| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.2M | +176.2% |
| SG&A Expense | $8.2M | +41.6% |
| Operating Income | -$11.4M | -64.4% |
| Net Income | -$13.0M | -85.6% |
| EPS (Basic) | -$28.25 | -3994.2% |
| EPS (Diluted) | -$28.25 | -3994.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.8M | -52.2% |
| Current Assets | $2.9M | -29.3% |
| Total Assets | $3.0M | -28.8% |
| Current Liabilities | $2.7M | +49.0% |
| Total Liabilities | $2.7M | +49.0% |
| Stockholders' Equity | $259K | -88.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.0M | -26.0% |
| Capital Expenditures | $8K | +166.7% |
| Investing Cash Flow | -$8K | -100.2% |
| Financing Cash Flow | $10.8M | +214.6% |
| Free Cash Flow | -$9.0M | -26.1% |